Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology | |
Zhang Xuchao; Liang Zhiyong; Wang Shengyue; Lu Shun; Song Yong; Cheng Ying; Ying Jianming; Liu Weiping; Hou Yingyong; Li Yangqiu | |
2019 | |
卷号 | 16期号:1页码:189-204 |
关键词 | Next-generation sequencing technology cancer consensus |
ISSN号 | 2095-3941 |
DOI | 10.20892/j.issn.2095-3941.2018.0142 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED ; CSCD |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6343526 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Zhang Xuchao,Liang Zhiyong,Wang Shengyue,et al. Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology[J],2019,16(1):189-204. |
APA | Zhang Xuchao.,Liang Zhiyong.,Wang Shengyue.,Lu Shun.,Song Yong.,...&Tumor Biomarker Committee On Behalf Of Chinese Soc.(2019).Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology.,16(1),189-204. |
MLA | Zhang Xuchao,et al."Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology".16.1(2019):189-204. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论